Physician profile
Ryan R Scott
NPI 1871756031
$7,627.11
in general payments reported to CMS, 2019-2025
27 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,470 · 2020: $452 · 2021: $1,444 · 2022: $36.23 · 2023: $482 · 2024: $186 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,076 · Travel and Lodging: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.06 |
| Travel and Lodging | $149.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $2,800.00 | 2019 | |
| Wright Medical Technology, INC. | $1,545.91 | 2019-2020 | |
| Avanos Medical | $1,400.00 | 2021 | |
| Boston Scientific Corporation | $273.46 | 2019-2021 | |
| Stryker Corporation | $246.37 | 2020-2025 | Infinity Adaptis, Prostep Mica |
| Kowa Pharmaceuticals America, INC. | $209.03 | 2022-2023 | Seglentis |
| Restor3d, INC. | $152.28 | 2025 | |
| Abbott Laboratories | $144.94 | 2020-2025 | Proclaim |
| Inari Medical, INC. | $137.20 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Blue Earth Diagnostics | $115.06 | 2024-2025 | Posluma |
| Treace Medical Concepts, INC. | $83.02 | 2024 | |
| Sirtex Medical INC | $78.77 | 2019-2020 | |
| Biocompatibles, INC. | $67.60 | 2019 | |
| Angiodynamics, INC. | $60.52 | 2020 | |
| Progenics Pharmaceuticals, INC. | $50.76 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $33.05 | 2025 | Lynparza |
| Verity Pharmaceuticals INC. | $31.27 | 2024 | Trelstar |
| Profound Medical Corp. | $23.22 | 2025 | Tulsa-Pro |
| Incyte Corporation | $22.76 | 2023 | Jakafi |
| Bioprotect Medical, INC. | $22.66 | 2025 | Bioprotect Balloon Implant System |
| Terumo Medical Corporation | $22.63 | 2024 | Angio-Seal |
| Cook Medical LLC | $22.41 | 2019 | |
| Ethicon US, LLC | $20.44 | 2020 | |
| Dendreon Pharmaceuticals LLC | $18.50 | 2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $15.66 | 2025 | |
| Siemens Medical Solutions USA, INC. | $15.50 | 2019 | |
| Immunitybio, INC. | $14.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.